Jiang C - Search Results

1

SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy.

Wang P, Qiu J, Fang Y, Li S, Liu K, Cao Y, Zhang G, Wang Z, Gu X, Wu J, Jiang C. Wang P, et al. Among authors: jiang c. Cell Death Differ. 2025 Jan 4. doi: 10.1038/s41418-024-01437-9. Online ahead of print. Cell Death Differ. 2025. PMID: 39755756

2

Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.

Wang ZX, Jiang CP, Cao Y, Zhang G, Chen WB, Ding YT. Wang ZX, et al. Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):178-85. doi: 10.1016/s1499-3872(15)60353-8. Hepatobiliary Pancreat Dis Int. 2015. PMID: 25865691

3

Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.

Liu Y, Wang ZX, Cao Y, Zhang G, Chen WB, Jiang CP. Liu Y, et al. Hepatobiliary Pancreat Dis Int. 2016 Jun;15(3):266-74. doi: 10.1016/s1499-3872(16)60094-2. Hepatobiliary Pancreat Dis Int. 2016. PMID: 27298102

4

Long noncoding RNA SNHG4 promotes the malignant progression of hepatocellular carcinoma through the miR-211-5p/CREB5 axis.

Qiu J, Wang P, Chen Z, Zhou Y, Zhang G, Wang Z, Wu J, Zhu Q, Jiang C. Qiu J, et al. Among authors: jiang c. Cancer Med. 2023 Apr;12(7):8388-8402. doi: 10.1002/cam4.5559. Epub 2022 Dec 23. Cancer Med. 2023. PMID: 36565037 Free PMC article.

5

Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy.

Ma C, Cao Y, Zhang G, Qiu J, Zhou Y, Wang P, Wang S, Yan D, Ma D, Jiang C, Wang Z. Ma C, et al. Among authors: jiang c. J Hepatocell Carcinoma. 2023 Feb 9;10:217-230. doi: 10.2147/JHC.S391755. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 36798739 Free PMC article.

6

UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.

Wu J, Xu X, Wu S, Shi W, Zhang G, Cao Y, Wang Z, Wu J, Jiang C. Wu J, et al. Among authors: jiang c. Cancer Med. 2023 Sep;12(17):18078-18097. doi: 10.1002/cam4.6431. Epub 2023 Aug 10. Cancer Med. 2023. PMID: 37563971 Free PMC article.

7

CuET overcomes regorafenib resistance by inhibiting epithelial-mesenchymal transition through suppression of the ERK pathway in hepatocellular carcinoma.

Ma D, Liu S, Liu K, He Q, Hu L, Shi W, Cao Y, Zhang G, Xin Q, Wang Z, Wu J, Jiang C. Ma D, et al. Among authors: jiang c. Transl Oncol. 2024 Sep;47:102040. doi: 10.1016/j.tranon.2024.102040. Epub 2024 Jul 1. Transl Oncol. 2024. PMID: 38954975 Free PMC article.

8

Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy.

Liu K, Kong L, Cui H, Zhang L, Xin Q, Zhuang Y, Guo C, Yao Y, Tao J, Gu X, Jiang C, Wu J. Liu K, et al. Among authors: jiang c. Cell Rep Med. 2024 Oct 15;5(10):101751. doi: 10.1016/j.xcrm.2024.101751. Epub 2024 Oct 1. Cell Rep Med. 2024. PMID: 39357524 Free PMC article.

9

Diverse roles of miR-29 in cancer (review).

Jiang H, Zhang G, Wu JH, Jiang CP. Jiang H, et al. Oncol Rep. 2014 Apr;31(4):1509-16. doi: 10.3892/or.2014.3036. Epub 2014 Feb 20. Oncol Rep. 2014. PMID: 24573597 Review.

10

Targeted co-delivery of Beclin 1 siRNA and FTY720 to hepatocellular carcinoma by calcium phosphate nanoparticles for enhanced anticancer efficacy.

Wu JY, Wang ZX, Zhang G, Lu X, Qiang GH, Hu W, Ji AL, Wu JH, Jiang CP. Wu JY, et al. Int J Nanomedicine. 2018 Mar 5;13:1265-1280. doi: 10.2147/IJN.S156328. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29551896 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,642 results

Search Page

Filters